Trials / Completed
CompletedNCT00086268
Non-small Cell Lung Cancer Study US75 (Z-PACT)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zoledronic acid | |
| DRUG | Taxotere | |
| DRUG | Carboplatin |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2004-07-01
- Last updated
- 2017-09-13
Locations
80 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00086268. Inclusion in this directory is not an endorsement.